A phase I study of nelfinavir....pdf

A phase I study of nelfinavir....pdf

ID:34931911

大?。?55.87 KB

頁數(shù):8頁

時間:2019-03-14

A phase I study of nelfinavir....pdf_第1頁
A phase I study of nelfinavir....pdf_第2頁
A phase I study of nelfinavir....pdf_第3頁
A phase I study of nelfinavir....pdf_第4頁
A phase I study of nelfinavir....pdf_第5頁
資源描述:

《A phase I study of nelfinavir....pdf》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在學術(shù)論文-天天文庫。

1、JNeurooncolDOI10.1007/s11060-013-1303-3CLINICALSTUDYAphaseIstudyofnel?navirconcurrentwithtemozolomideandradiotherapyinpatientswithglioblastomamultiformeMichelleAlonso-Basanta?PennyFang?AmitMaity?StephenM.Hahn?RobertA.Lustig?JayF.DorseyReceived:10May2013/Accepted:21October2013óSpring

2、erScience+BusinessMediaNewYork2013AbstractWeconductedaphaseItrialtoexaminethe1,250mgbiddoselevel,patientsshouldbemonitoredformaximallytolerateddose(MTD)oftheoralproteasehepatotoxicityandGIsideeffects.inhibitornel?navir(NFV)incombinationwithtemozolo-mideandconcurrentradiotherapyinpat

3、ientswithglio-KeywordsNel?navirGlioblastomaMalignantblastomaandtogatherpreliminarydataforresponse.ThegliomaRadiationtherapyRadiosensitizerstudywasconductedinpatientswithnewlydiagnosedglioblastomaaftersurgicalresection.Patientsweretreatedwithstandardradiotherapy(6,000cGytothegros

4、stumorIntroduction2volume),temozolomide(75mg/mdaily)togetherwithdailyoralNFVstarting7–10dayspriortochemoradio-Glioblastomamultiforme(GBM)isthemostfrequentpri-therapycontinuingforthedurationofchemoradiationformarymalignantbraintumorinadults.Thestandardofcare26weeks.Temozolomide(150–2

5、00mg/m)wasresumedofnewlydiagnosedglioblastomafollowingsurgical4weeksaftercompletionofchemoradiotherapy.Twodoseresectiontotheextentsafelyfeasibleisconcurrenttem-levelsofNFVwereinvestigated:625mgtwicedaily(bid)ozolomidewithradiotherapyfollowedbymonthlytem-and1,250mgbidinacohortescalat

6、iondesign.Atotalofozolomidefor5dayseachmonthforatleast6cycles[1].21patientswereenrolled.Atthemaximumtolerateddose,Thiscourseoftherapyresultsinamediansurvivalof18subjectswereenrolledtofurtherevaluatetoxicityand14.6monthsandaprogression-freesurvivalofaboutforpreliminaryestimateofef?ca

7、cyforfurtherphaseII6.9monthsascomparedwithmediansurvivalofstudy.Nodose-limitingtoxicitywasnotedat625mgbid.12.1monthswithradiotherapyalone[1].However,thisAt1,250mgbid,3dose-limitingepisodesofhepatotox-standardtherapystillonlyresultsinamodestsurvivalicitywerenotedandonedose-limitingep

8、isodeofdiarrhea.ben

當前文檔最多預覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當前文檔最多預覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學公式或PPT動畫的文件,查看預覽時可能會顯示錯亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負責整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時聯(lián)系客服。
3. 下載前請仔細閱讀文檔內(nèi)容,確認文檔內(nèi)容符合您的需求后進行下載,若出現(xiàn)內(nèi)容與標題不符可向本站投訴處理。
4. 下載文檔時可能由于網(wǎng)絡波動等原因無法下載或下載錯誤,付費完成后未能成功下載的用戶請聯(lián)系客服處理。